Target Price | $90.89 |
Price | $52.51 |
Potential |
73.09%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target Keros Therapeutics Inc 2025 .
The average Keros Therapeutics Inc target price is $90.89.
This is
73.09%
register free of charge
$105.00
99.96%
register free of charge
$77.00
46.64%
register free of charge
|
|
A rating was issued by 10 analysts: 10 Analysts recommend Keros Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Keros Therapeutics Inc stock has an average upside potential 2025 of
73.09%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.15 | 5.72 |
3,716.00% | ||
EBITDA Margin | -112,753.33% | -3,258.23% |
97.11% | ||
Net Margin | -125,389.33% | -3,067.88% |
97.55% |
10 Analysts have issued a sales forecast Keros Therapeutics Inc 2024 . The average Keros Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Keros Therapeutics Inc EBITDA forecast 2024. The average Keros Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Keros Therapeutics Inc Analysts have issued a net profit forecast 2024. The average Keros Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -5.20 | -4.86 |
25.30% | 6.54% | |
P/E | negative | |
EV/Sales | 275.75 |
8 Analysts have issued a Keros Therapeutics Inc forecast for earnings per share. The average Keros Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Keros Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Keros Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.